# A Clinical Study of AK139 in Healthy Subjects

> **NCT06947109** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Akeso** · enrollment: 48 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Placebo
- **DRUG:** AK111

## Key facts

- **NCT ID:** NCT06947109
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-06
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-01-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06947109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06947109, "A Clinical Study of AK139 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06947109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*